Joincare Pharmaceutical Group Industry Co., Ltd

This study tested a new inhaled medicine called JKN2304 in 42 people with moderate to severe COPD. The goal was to see if it is safe and helps improve breathing compared to a placebo or an existing drug. Participants took the medicine for 14 days, and researchers measured lung fu…

This early-stage study tested the safety and tolerability of an inhaled drug called DBM-1152A in 20 healthy Chinese adults. Participants received either the drug or a placebo once daily for 7 days. The goal was to check for side effects and how the drug moves through the body, no…

This early-stage study tested a single inhaled dose of DBM-1152A in 44 healthy Chinese adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either the drug or a placebo. The goal was to check for side effects and measure drug l…

This early-stage study tested a single dose of a new drug called JKN2306 in 44 healthy adults in China. The main goal was to check if it is safe and how the body processes it, including whether a high-fat meal changes its effects. The study did not treat pain directly but gathere…